‹#›
RTOG 0617:
60 Gy
74 Gy
Local Failure
30%
39% (ns)
PFS
29%
21%
Distant mets
46%
51%
Overall Survival
57%
44% (ss)
Median survival
29 months
20 months
•
Trial was stopped because of increased risk of fatalities in high-dose arm
Does this even make sense?